Clinical trials
catalyst calendar across sponsors →Studies where MKC is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional
Held by 18 tracked-famous managers (AQR CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Verition Fund Management LLC, MARSHALL WACE, LLP, +13 more) · FINRA short interest 3.8 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Bioavailability Study of Cinnamon in Healthy SubjectsNCT01847053The primary outcome variables will be the area under the curve (AUC) from 0 to 360 min for plasma procyanidin-derived metabolites.Randomized · Triple-masked · Basic science | Phase 1/2 | Completed | Other: cinnamon, Oatmeal | Healthy Males | 8 | Dec 2013actual | 2020-03-06 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19